Furthermore, structural prediction postulates that A159V could retain in its GTP-bound (active) form for much longer than P29S, suggesting the need for the functional characterization of this likely hyperactive RAC1 mutant in the context of HNSCC [18]. This evidence concerns the gene RAC1 and head and neck squamous cell carcinoma.